Problems for Pfizer



[ad_1]

Pfizer can only administer half of the vaccines expected this year. Write the Wall Street Journal.

The company came out in November and said it would deliver 100 million doses of vaccines worldwide by 2020. Now the number is moderating to 50 million.

Pfizer came out in November and said that if the vaccine was approved, the drug company could ship 20 million doses of the vaccine in a matter of hours. According to the Wall Street Journal, this is due to problems with the distribution of the vaccine. However, Pfizer is expected to deliver more than 1 billion doses in 2021.

Pfizer: Ready to Ship Vaccines

Pfizer: Ready to Ship Vaccines

– Expansion of raw material deliveries took longer than expected. Also, the main test results came later than we expected, says a Wall Street Journal spokesperson.

The Pfizer vaccine is one of the candidates that may be available in the EU and Norway, if the vaccine is approved. Raw materials are delivered from US and European suppliers, but the company itself would not comment on where the delivery problems arose.

The problems that Pfizer has ended up with illustrate how different development is from the corona vaccine. Typically, a vaccine manufacturer waits to purchase raw materials for production until after the vaccine has been approved.

CLEAR: The Norwegian Medicines Agency’s chief physician, Sigurd Hortemo, believes that vaccination can begin quickly when a vaccine is approved for the first time.
see more

Pfizer has never before produced a vaccine that uses so-called mRNA technology.

– For this vaccine, everything has happened at the same time. We started setting up supply chains in March, when the vaccine was still in development. It has never happened before, says a Pfizer employee with whom the Wall Street Journal spoke.

The delivery problems could have consequences for the UK, which approved the Pfizer vaccine and ordered 40 million doses.

VACCINE: Health Director Bjørn Guldvog talks about what the lead-up time can be like. Reporter: Frode Andresen. Video: Bjørge Dahle Johansen.
see more

Norway also hopes to be able to start mass vaccination with the Pfizer vaccine, but it is up to the EU to approve it first. This is expected to happen at a meeting on December 29.

According to the drug’s manufacturer, the Pfizer vaccine provides protection against COVID-19 in 95 percent of cases. No serious side effects have been reported. The vaccine is taken in two doses, three weeks apart, and is expected to cost around 180 crowns per dose.

[ad_2]